Company: BSX
Filing Date: 2025-02-24
Form Type: 424B2
Source: 0001104659-25-016521
Chunk: 27

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-02-24
Form: 424B2
Chunk 27
---
 extent that any of the net proceeds from this offering are used to fund the repayment at maturity of the March 2025 Notes, such underwriters or affiliates will receive a portion of the proceeds from this offering.

<div align='center'>S-13</div>

TABLE OF CONTENTS

### DESCRIPTION OF THE NOTES
The following description of the particular terms of the notes offered hereby (referred to in the accompanying prospectus as the “Debt Securities”) supplements, and to the extent inconsistent therewith replaces, the description of the general terms and provisions of the Debt Securities set forth in the accompanying prospectus under the heading “Description of Debt Securities,” to which description reference is hereby made. The following summaries of certain provisions of the indenture do not purport to be complete, and are subject to, and are qualified in their entirety by reference to, all the provisions of the indenture, including the definitions in the indenture of certain terms and other terms made part of the indenture. As used in this description, unless otherwise expressly stated or the context otherwise requires, all references to the “issuer,” “AMS Europe,” “we,” “us,” or “our” mean American Medical Systems Europe B.V. excluding its subsidiaries and all references to “Boston Scientific” or the “guarantor” mean Boston Scientific Corporation excluding its subsidiaries.

#### General
The 2031 Notes offered hereby will be limited initially to €850,000,000 aggregate principal amount and will mature on March 8, 2031. The 2034 Notes offered hereby will be limited initially to €650,000,000 aggregate principal amount and will mature on March 8, 2034. The notes will not be entitled to a sinking fund. The notes of each series will bear interest from the date of issuance, payable annually in arrears on March 8 of each year, beginning March 8, 2026, to the persons in whose names such notes are registered at the close of business on the business day (for this purpose, a day on which Clearstream and Euroclear are open for business) immediately preceding the relevant interest payment date. Interest on the notes will be computed on the basis of the actual number of days in the period for which interest is being calculated and the actual number of days from and including the last date on which interest was paid on the notes (or February 26, 2025, if no interest has been paid on the notes), to, but excluding, the next scheduled interest payment date. This